Thalamic atrophy a biomarker of multiple sclerosis

Researchers from Australia and the Czech Republic conducted a study imaging the brains of 216 patients who had experienced clinically isolated syndrome, a short-term neurological episode which often precedes MS diagnosis.

The patients had several MRIs over two years.

At the end of the study, 92 of them (nearly 43%) converted to MS.

The researchers found thalamic atrophy was independently associated with development of MS, making it “an ideal biomarker”.